You are here

SBIR PHASE I ANTIBODY ARRAY FOR CANCER DETECTION (TOPIC236)

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: N43CN0800020
Agency Tracking Number: N43CN0800020
Amount: $150,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: 2008
Award Year: 2008
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
PHARMASEQ, INC. 11 DEER PARK DR, STE 104
MONMOUTH JUNCTION, NJ 08852
United States
DUNS: 027661870
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Wlodek Mandecki
 (732) 355-0100
 mandecki@pharmaseq.com
Business Contact
Phone: (732) 355-0100
Email: mandecki@pharmaseq.com
Research Institution
N/A
Abstract

This Phase I project aims to develop a technology to simultaneously measure three biomarkders for early prostate cancer detection using an electronic radio frequency (RF) light-powered microtransponder. Antigens will be captured using antibodies coupled to the microtransponders and detected using biotinylated antibodies.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government